A Study to Evaluate the Safety of bb2121 in Subjects With High Risk, Newly Diagnosed Multiple Myeloma (NDMM)

Local Institution - 121, New York

Local Institution - 109, New York

Local Institution - 124, New York

Local Institution - 118, Philadelphia

Local Institution - 120, Charlotte

Local Institution - 108, Atlanta

Local Institution - 123, Atlanta

Local Institution - 101, Jacksonville

Local Institution - 113, Tampa

Local Institution - 103, Nashville

Local Institution - 102, Dallas

Local Institution - 114, Houston

Local Institution - 106, Denver

Local Institution - 119, Phoenix

Local Institution - 110, Los Angeles

Local Institution - 116, San Francisco

Local Institution - 112, Portland

Local Institution - 115, Boston

Local Institution - 122, Boston

Local Institution - 117, Hackensack

Local Institution - 104, Seattle

Local Institution - 107, Milwaukee